Patent Prosecutors Alarmed By Inequitable Conduct Ruling
A Federal Circuit decision finding a Regeneron Pharmaceuticals Inc. patent unenforceable due to inequitable conduct based partly on the behavior of litigators in an infringement case has alarmed attorneys who seek...To view the full article, register now.
Already a subscriber? Click here to view full article